Search research articles
Contact Us
Filters
Showing results (61-70 of 189) with videos related to
Page
of 19
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 14, 2017
WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research
Harald Hampel, Marsel M Mesulam, A Claudio Cuello, et al.
Brain Research. Molecular Brain Research
|
October 26, 2002
NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line
Feng Gao, Kelly R Bales, Richard C Dodel, et al.
Journal of Alzheimer'S Disease : JAD
|
April 3, 2022
Measuring Subjective Cognitive Decline in Older Adults: Harmonization Between the Cognitive Change Index and the Measurement of Everyday Cognition Instruments
Lindsey F Wells, Shannon L Risacher, Brenna C McDonald, et al.
Journal of the Endocrine Society
|
December 25, 2024
Sex Differences in Basal Cortisol Levels Across Body Fluid Compartments in a Cross-sectional Study of Healthy Adults
Katharine J Liang, Elizabeth A Colasurdo, Ge Li, et al.
Brain : a Journal of Neurology
|
October 8, 2004
Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury
Xing Wei, Liming Zhao, Zhizhong Ma, et al.
Canadian Journal of Experimental Psychology = Revue Canadienne De Psychologie Experimentale
|
May 9, 2017
Cognitive modeling as an interface between brain and behavior: Measuring the semantic decline in mild cognitive impairment
Brendan T Johns, Vanessa Taler, David B Pisoni, et al.
Journal of Alzheimer'S Disease : JAD
|
December 12, 2018
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease
Martin R Farlow, Richard E Thompson, Lee-Jen Wei, et al.
Neuro-Degenerative Diseases
|
March 7, 2008
In vivo and postmortem clinicoanatomical correlations in frontotemporal dementia and parkinsonism linked to chromosome 17
Bernardino Ghetti, Salvatore Spina, Jill R Murrell, et al.
Clinical Therapeutics
|
August 4, 2010
Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study
Martin R Farlow, Stephen Salloway, Pierre N Tariot, et al.
Molecular Neurobiology
|
July 21, 2018
IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease
Huiying Gu, Yvonne Kirchhein, Timothy Zhu, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 189) with videos related to
Sort By:
Page
of 19
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 14, 2017
WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research
Harald Hampel, Marsel M Mesulam, A Claudio Cuello, et al.
Brain Research. Molecular Brain Research
|
October 26, 2002
NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line
Feng Gao, Kelly R Bales, Richard C Dodel, et al.
Journal of Alzheimer'S Disease : JAD
|
April 3, 2022
Measuring Subjective Cognitive Decline in Older Adults: Harmonization Between the Cognitive Change Index and the Measurement of Everyday Cognition Instruments
Lindsey F Wells, Shannon L Risacher, Brenna C McDonald, et al.
Journal of the Endocrine Society
|
December 25, 2024
Sex Differences in Basal Cortisol Levels Across Body Fluid Compartments in a Cross-sectional Study of Healthy Adults
Katharine J Liang, Elizabeth A Colasurdo, Ge Li, et al.
Brain : a Journal of Neurology
|
October 8, 2004
Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury
Xing Wei, Liming Zhao, Zhizhong Ma, et al.
Canadian Journal of Experimental Psychology = Revue Canadienne De Psychologie Experimentale
|
May 9, 2017
Cognitive modeling as an interface between brain and behavior: Measuring the semantic decline in mild cognitive impairment
Brendan T Johns, Vanessa Taler, David B Pisoni, et al.
Journal of Alzheimer'S Disease : JAD
|
December 12, 2018
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease
Martin R Farlow, Richard E Thompson, Lee-Jen Wei, et al.
Neuro-Degenerative Diseases
|
March 7, 2008
In vivo and postmortem clinicoanatomical correlations in frontotemporal dementia and parkinsonism linked to chromosome 17
Bernardino Ghetti, Salvatore Spina, Jill R Murrell, et al.
Clinical Therapeutics
|
August 4, 2010
Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study
Martin R Farlow, Stephen Salloway, Pierre N Tariot, et al.
Molecular Neurobiology
|
July 21, 2018
IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease
Huiying Gu, Yvonne Kirchhein, Timothy Zhu, et al.
Page
of 19